Pantheon has agreed a €548m infrastructure secondary transaction with Natixis Investment Managers affiliate Mirova, providing liquidity to existing fund investors while bringing fresh capital into a portfolio of European renewable energy businesses.
The New York State Teachers' Retirement System has unveiled more than $1bn of new private markets commitments alongside an update that its venture capital and growth equity investments continue to underperform their benchmarks.
Venture capital fund-of-funds manager Allocator One has emerged from stealth after closing its inaugural flagship vehicle above target, with total commitments across its investment vehicles exceeding $100m.
Detroit-based Mudita Venture Partners has closed its second fund at $120m, tripling the size of its debut vehicle as it expands its investments in early-stage business-to-business AI companies.
Lovell Minnick has named Jason Barg as its next co-managing partner as part of a wider leadership reshuffle that will see longtime co-head Bob Belke step back from the role ahead of his retirement at the end of 2027.
AI drug discovery specialist Isomorphic Labs has raised $5bn in a Series C financing co-led by Greenoaks and Sequoia Capital, with participation from Andreessen...
CVC Capital Partners has named TPG president Todd Sisitsky and its own president Peter Rutland as its next co-chief executives, setting out a leadership succession that will see Rob Lucas step back from the top role by the first quarter of 2028.
MetLife Investment Management has raised $370m for an opportunistic commercial real estate debt fund targeting US property owners seeking financing for refinancing, asset repositioning and transitional business plans.
Argonaut Private Equity has raised $606m for its sixth fund, more than 20% above its last fund, as it continues targeting industrial and manufacturing businesses across underserved US markets.
Blue Sea Capital has raised $800m for its fourth private equity fund, beating its original $700m hard cap as it shifts to a strategy dedicated exclusively to healthcare investments.